Found: 16
Select item for more details and to access through your institution.
Biosimilars and the extrapolation of indications for inflammatory conditions.
- Published in:
- Biologics: Targets & Therapy, 2017, v. 11, p. 5, doi. 10.2147/BTT.S124476
- By:
- Publication type:
- Article
A multicentre, efficacy and safety study of methotrexate to increase response rates in patients with uncontrolled gout receiving pegloticase (MIRROR): 12-month efficacy, safety, immunogenicity, and pharmacokinetic findings during long-term extension of an open-label study
- Published in:
- Arthritis Research & Therapy, 2022, v. 24, n. 1, p. 1, doi. 10.1186/s13075-022-02865-z
- By:
- Publication type:
- Article
Biosimilars Have Arrived: Rituximab.
- Published in:
- Arthritis (20901984), 2018, p. 1, doi. 10.1155/2018/3762864
- By:
- Publication type:
- Article
Improvements in Patient‐Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real‐World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- ACR Open Rheumatology, 2024, v. 6, n. 5, p. 304, doi. 10.1002/acr2.11657
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Placebo‐Controlled Multicenter Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving Pegloticase: 12‐Month Findings.
- Published in:
- ACR Open Rheumatology, 2023, v. 5, n. 8, p. 407, doi. 10.1002/acr2.11578
- By:
- Publication type:
- Article
A Randomized, Double‐Blind, Sham‐Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 12, p. 2107, doi. 10.1002/art.42637
- By:
- Publication type:
- Article
A Randomized, Placebo‐Controlled Study of Methotrexate to Increase Response Rates in Patients with Uncontrolled Gout Receiving Pegloticase: Primary Efficacy and Safety Findings.
- Published in:
- Arthritis & Rheumatology, 2023, v. 75, n. 2, p. 293, doi. 10.1002/art.42335
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib in patients with rheumatoid arthritis by previous treatment: post hoc analysis of phase II/III trials.
- Published in:
- Arthritis Research & Therapy, 2023, v. 25, n. 1, p. 1, doi. 10.1186/s13075-023-03154-z
- By:
- Publication type:
- Article
Six-Month Persistence and Multi-domain Effectiveness of Guselkumab in Adults with Psoriatic Arthritis: Real-World Data from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.
- Published in:
- Rheumatology & Therapy, 2023, v. 10, n. 6, p. 1479, doi. 10.1007/s40744-023-00582-w
- By:
- Publication type:
- Article
Efficacy and safety of intravenous golimumab plus methotrexate in patients with rheumatoid arthritis aged < 65 years and those ≥ 65 years of age.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-1968-x
- By:
- Publication type:
- Article
Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT).
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 7, p. 663, doi. 10.3899/jrheum.2023-1062
- By:
- Publication type:
- Article
Pegloticase in Combination With Methotrexate in Patients With Uncontrolled Gout: A Multicenter, Open-label Study (MIRROR).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Durable control of psoriatic arthritis with guselkumab across domains and patient characteristics: post hoc analysis of a phase 3 study.
- Published in:
- Clinical Rheumatology, 2024, v. 43, n. 8, p. 2551, doi. 10.1007/s10067-024-06991-8
- By:
- Publication type:
- Article
Improvement in disease activity among patients with rheumatoid arthritis who switched from intravenous infliximab to intravenous golimumab in the ACR RISE registry.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 8, p. 2319, doi. 10.1007/s10067-022-06116-z
- By:
- Publication type:
- Article
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2127, doi. 10.1007/s10067-020-04956-1
- By:
- Publication type:
- Article
Ethnographic Observational Study of the Biologic Initiation Conversation Between Rheumatologists and Biologic-Naive Rheumatoid Arthritis Patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article